Latest Dexcel Pharma News & Updates

See the latest news and media coverage for Dexcel. We track all announcements, press releases, and industry mentions in real time, all in one place.

Dexcel Pharma (Dexcel)

Developer, manufacturer, and marketer of pharmaceuticals

dexcel.com

Headquarters: Or Akiva, Israel
Founded year: 1968
Company type: Private company
Number of employees: 500–1,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Dexcel Pharma (Dexcel)

In short: Dexcel expanded its U.S. presence by acquiring Zubsolv and advanced its pharmaceutical pipeline through the launch of Syremis Therapeutics.

Company announcements

January 19 Dexcel

Dexcel presented in vitro testing research at Isranalytica

The lecture by Tomer Ram covered challenges, insights, and regulatory aspects of in vitro testing for enteral feeding tubes.

January 19 Dexcel

Dexcel presented research on in vitro testing of oral drugs

Tomer Ram presented the company's work at the Isranalytica conference, focusing on challenges and regulatory aspects.

January 15 Dexcel

Dexcel acquires Zubsolv business from Orexo

The U.S. commercial business of Zubsolv, an opioid use disorder treatment, was acquired to strengthen Dexcel's portfolio and U.S. presence.

24 December 2025 Dexcel

Dexcel's RNA therapy DXO-1801 progresses

The experimental treatment is intended for anemia due to inflammation, presented promising results in animals, and human trials are expected in about a year.

Media coverage

May 18 The Pharma Letter

Dexcel Pharma Technologies

A vertically integrated Israeli specialty pharma company developing and manufacturing modified-release and controlled-release oral drug products, with a growing portfolio spanning cardiovascular, CNS, and urology...

22 December 2025 UK Share Prices

Orexo Enters Into Agreement with Dexcel Pharma USA to Divest US Rights to Zubsolv

· An asset purchase agreement has been signed with Dexcel Pharma USA, which will acquire the full rights to Zubsolv® in the US, at a...

31 May 2024 The Globe and Mail

Orexo Sells US Rights to Zubsolv to Dexcel to Repay Debt and Fund AmorphOX Pipeline

An update from Orexo AB ( (SE:ORX)) is now available. Orexo AB has agreed to sell the full US rights to its opioid use disorder...

31 May 2007 Fierce Pharma

Dexcel gets right to sell copycat Prilosec

The fight is over. Over-the-counter drug distributor Perrigo said its partner Dexcel Pharma Technologies has settled patent litigation with AstraZeneca over the heartburn med Prilosec...

Never miss news about Dexcel

Track Dexcel and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Dexcel competitors & trending companies

Browse news for competitors to Dexcel and other trending companies.